视网膜疾病黄斑液体的自动量化及其对抗VEGF治疗的反应
结果显示各疾病IRF以黄斑中心凹最高,SRF在nAMD中旁中心环高于中心凹至第3月,RVO/DME中IRF以颞侧最高,SRF下方始终多于上方,并报告了第1/12月液体体积中位下降比例。
要点
- 各疾病各时间点IRF每平方毫米以中心凹最高,旁中心环次之,周边环最低。
- nAMD患者SRF在旁中心环高于中心凹直至第3月,RVO/DME则中心凹最高。
- RVO/DME患者IRF体积以颞侧最高,各疾病SRF下方始终多于上方。
核心结论
- 全自动定位和量化IRF/SRF可揭示各疾病液体动态,且各疾病对抗VEGF治疗有特定的解剖学反应。
研究设计与样本
- 用深度学习算法在基线及第1、2、3、12月测量三个同心圆(直径1、3、6 mm,即中心凹、旁中心环、周边环)及四个象限的液体体积。
主要发现
- 各疾病各时间点IRF每平方毫米以中心凹最高,旁中心环次之,周边环最低(p<0.0001)。
- RVO/DME的SRF同样以中心凹最高(p<0.0001),但nAMD患者旁中心环SRF高于中心凹直至第3月(p<0.0001)。
- RVO/DME患者IRF体积以颞侧最高(p<0.001/p<0.0001),各疾病SRF下方始终多于上方(p<0.02)。
- 第1/12月IRF中位下降:RVO 95.9%/97.7%,nAMD 91.3%/92.8%,DME 37.3%/69.9%。
- 第1/12月SRF中位下降:RVO 94.7%/97.5%,nAMD 98.4%/99.8%,DME 86.3%/97.5%。
临床怎么用
- 可利用AI自动量化OCT液体体积及空间分布,客观评估RVO、nAMD和DME的疾病活动度及抗VEGF治疗反应。
- 解读液体变化时需考虑疾病特异的解剖模式,如nAMD旁中心环SRF可高于中心凹、RVO/DME颞侧IRF最高、SRF下方多于上方。
- DME的IRF下降比例低于RVO和nAMD,提示不同疾病对抗VEGF的液体清除反应存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To objectively assess disease activity and treatment response in patients with retinal vein occlusion (RVO), neovascular age-related macular degeneration (nAMD) and centre-involved diabetic macular oedema (DME), using artificial intelligence-based fluid quantification. METHODS: Posthoc analysis of 2311 patients (11 151 spectral-domain optical coherence tomography volumes) from five clinical, multicentre trials, who received a flexible antivascular endothelial growth factor (anti-VEGF) therapy over a 12-month period. Fluid volumes were measured with a deep learning algorithm at baseline/months 1, 2, 3 and 12, for three concentric circles with diameters of 1, 3 and 6 mm (fovea, paracentral ring and pericentral ring), as well as four sectors surrounding the fovea (superior, nasal, inferior and temporal). RESULTS: In each disease, at every timepoint, most intraretinal fluid (IRF) per square millimetre was present at the fovea, followed by the paracentral ring and pericentral ring (p<0.0001). While this was also the case for subretinal fluid (SRF) in RVO/DME (p<0.0001), patients with nAMD showed more SRF in the paracentral ring than at the fovea up to month 3 (p<0.0001). Between sectors, patients with RVO/DME showed the highest IRF volumes temporally (p<0.001/p<0.0001). In each disease, more SRF was consistently found inferiorly than superiorly (p<0.02). At month 1/12, we measured the following median reductions of initial fluid volumes. For IRF: RVO, 95.9%/97.7%; nAMD, 91.3%/92.8%; DME, 37.3%/69.9%. For SRF: RVO, 94.7%/97.5%; nAMD, 98.4%/99.8%; DME, 86.3%/97.5%. CONCLUSION: Fully automated localisation and quantification of IRF/SRF over time shed light on the fluid dynamics in each disease. There is a specific anatomical response of IRF/SRF to anti-VEGF therapy in all diseases studied.
引用
- Michl M, Fabianska M, Seeböck P, et al. Automated quantification of macular fluid in retinal diseases and their response to anti-VEGF therapy. Br J Ophthalmol. 2020. PMID: 33087314. doi:10.1136/bjophthalmol-2020-317416
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。